- Home
- BYFC vs PYPD Comparison
BYFC vs PYPD Comparison
Compare BYFC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- PYPD
- Stock Information
- Founded
- BYFC 1946
- PYPD 2008
- Country
- BYFC United States
- PYPD Israel
- Employees
- BYFC N/A
- PYPD N/A
- Industry
- BYFC Savings Institutions
- PYPD Medical/Dental Instruments
- Sector
- BYFC Finance
- PYPD Health Care
- Exchange
- BYFC Nasdaq
- PYPD Nasdaq
- Market Cap
- BYFC 57.1M
- PYPD 60.4M
- IPO Year
- BYFC 1996
- PYPD 2020
- Fundamental
- Price
- BYFC $6.05
- PYPD $3.57
- Analyst Decision
- BYFC
- PYPD Strong Buy
- Analyst Count
- BYFC 0
- PYPD 5
- Target Price
- BYFC N/A
- PYPD $12.00
- AVG Volume (30 Days)
- BYFC 2.2K
- PYPD 88.4K
- Earning Date
- BYFC 10-31-2025
- PYPD 11-12-2025
- Dividend Yield
- BYFC N/A
- PYPD N/A
- EPS Growth
- BYFC N/A
- PYPD N/A
- EPS
- BYFC N/A
- PYPD N/A
- Revenue
- BYFC $33,412,000.00
- PYPD N/A
- Revenue This Year
- BYFC N/A
- PYPD N/A
- Revenue Next Year
- BYFC N/A
- PYPD N/A
- P/E Ratio
- BYFC N/A
- PYPD N/A
- Revenue Growth
- BYFC N/A
- PYPD N/A
- 52 Week Low
- BYFC $5.71
- PYPD $2.30
- 52 Week High
- BYFC $9.46
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- BYFC 28.80
- PYPD 55.21
- Support Level
- BYFC $6.15
- PYPD $3.51
- Resistance Level
- BYFC $6.49
- PYPD $3.81
- Average True Range (ATR)
- BYFC 0.11
- PYPD 0.14
- MACD
- BYFC -0.04
- PYPD -0.02
- Stochastic Oscillator
- BYFC 0.00
- PYPD 51.35
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.